Russia's announcement of a personalised mRNA cancer vaccine has generated excitement, but experts urge caution. While mRNA technology shows potential, the lack of clinical data and the gap between ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

Russia’s Gamaleya Research Institute, known for developing the Sputnik V COVID-19 vaccine, is close to gaining regulatory approval for a personalized mRNA cancer vaccine. According to the institute’s ...

To counteract these challenges, novel strategies aim to restore the cancer immunity cycle. One approach involves directly injecting unadjuvanted influenza vaccines or drug-loaded oncolytic viruses ...

Russia cancer vaccine could receive approval by August allowing treatment to begin the head of the Gamaleya Research ...

The Cancer Vaccines Market is witnessing significant expansion, driven by rising cancer prevalence and advancements in ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...

I think [this technology] will be among the most important things.' Similar experimental mRNA cancer vaccines have been in development since the technology was advanced during the Covid pandemic.

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...